Herpesvirus hominis type 2 infections in rabbits: effect of prior immunization with attenuated Mycobacterium bovis (BCG) cells

Infect Immun. 1972 Oct;6(4):465-8. doi: 10.1128/iai.6.4.465-468.1972.

Abstract

Angora, New Zealand, and Dutch-belted rabbits were tested for their susceptibility to graded doses of Herpesvirus hominis type 2 administered by vaginal instillation, intracorneal injection, and scarification of the cornea. Central nervous system involvement and death occurred after infection by the various routes employed. Prior immunization of Dutch-belted and New Zealand rabbits with viable Mycobacterium bovis (BCG) cells injected intravenously provided protection against subsequent infections with type 2 virus.

MeSH terms

  • Animals
  • Encephalitis / etiology
  • Female
  • Herpesviridae Infections / complications
  • Herpesviridae Infections / immunology*
  • Herpesviridae Infections / mortality
  • Immunization
  • Injections, Intravenous
  • Lethal Dose 50
  • Mycobacterium bovis / immunology*
  • Rabbits
  • Simplexvirus / immunology*
  • Simplexvirus / pathogenicity
  • Vaccination
  • Vaccines, Attenuated
  • Vagina

Substances

  • Vaccines, Attenuated